Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JANET PAN

NPI
1801056676
CMS profile
354136
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$7,888.97

348 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $7,863.02 347
Education $25.95 1

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $715.87 30
Janssen Biotech, Inc. $603.75 28
Alexion Pharmaceuticals, Inc. $571.71 17
Eisai Inc. $393.07 16
ABBVIE INC. $371.00 22
Merck Sharp & Dohme LLC $349.38 13
Novartis Pharmaceuticals Corporation $344.73 19
Takeda Pharmaceuticals U.S.A., Inc. $324.15 12
Lilly USA, LLC $312.08 13
PFIZER INC. $307.33 13
GlaxoSmithKline, LLC. $290.26 13
Incyte Corporation $264.49 11
Exelixis Inc. $257.03 9
Gilead Sciences, Inc. $191.68 8
Celgene Corporation $190.27 17
ARRAY BIOPHARMA INC $178.78 9
Regeneron Healthcare Solutions, Inc. $171.14 5
Daiichi Sankyo Inc. $145.31 6
E.R. Squibb & Sons, L.L.C. $141.63 14
PUMA BIOTECHNOLOGY, INC. $136.79 5
Karyopharm Therapeutics Inc. $125.86 5
Astellas Pharma US Inc $112.52 5
GENZYME CORPORATION $109.08 4
Coherus Biosciences Inc. $97.14 5
Bayer Healthcare Pharmaceuticals Inc. $88.53 5
Aveo Pharmaceuticals, Inc. $82.18 3
JAZZ PHARMACEUTICALS INC. $73.95 3
Boehringer Ingelheim Pharmaceuticals, Inc. $69.36 3
RECORDATI_RARE_DISEASES_INC. $69.14 3
BeiGene USA, Inc. $66.34 2
PharmaEssentia USA Corporation $64.82 2
Genentech USA, Inc. $62.95 2
TAIHO ONCOLOGY, INC. $60.09 3
Stemline Therapeutics Inc. $58.73 2
SOBI, INC $58.00 3
Ipsen Biopharmaceuticals, Inc $57.34 3
EMD Serono, Inc. $56.10 2
Blueprint Medicines Corporation $55.38 2
Sumitomo Pharma America, Inc. $54.84 3
Kite Pharma, Inc. $34.48 1
SUN PHARMACEUTICAL INDUSTRIES INC. $30.70 1
Tempus AI, Inc $29.48 1
ADC Therapeutics America, Inc. $29.45 1
Grifols USA, LLC $24.21 1
Rigel Pharmaceuticals, Inc. $23.02 1
Fennec Pharmaceuticals, Inc. $22.66 1
Emmaus Medical, Inc. $12.17 1

Page 5 of 7; records 201–250 of 348 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JANET PAN

NPI 1801056676 · CMS profile ID 354136

FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 7; records 201–250 of 348 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1801056676?year=2024&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 7; records 201–250 of 348 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1801056676?year=2024&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 7; records 201–250 of 348 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1801056676?year=2024&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JANET PAN, NPI 1801056676, CMS profile ID 354136, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 7; records 201–250 of 348 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1801056676?year=2024&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

348 matching records · $7,888.97 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 348 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 348.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $23.1905/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144964623 CMS
GlaxoSmithKline, LLC. $14.5905/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116280962 CMS
Novartis Pharmaceuticals Corporation $15.4305/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087232067 CMS
Incyte Corporation $10.1305/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141277516 CMS
Incyte Corporation $5.4905/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141277518 CMS
Genentech USA, Inc. $28.9505/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133026782 CMS
Janssen Biotech, Inc. $23.6605/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078296053 CMS
Lilly USA, LLC $28.7805/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135026878 CMS
ABBVIE INC. $2.9005/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105173980 CMS
Celgene Corporation $18.3405/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101142900 CMS
Gilead Sciences, Inc. $30.9505/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133767929 CMS
Janssen Biotech, Inc. $39.5305/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078295657 CMS
Alexion Pharmaceuticals, Inc. $34.6505/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094016060 CMS
E.R. Squibb & Sons, L.L.C. $7.2805/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101465088 CMS
TAIHO ONCOLOGY, INC. $20.5305/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137935705 CMS
Coherus Biosciences Inc. $16.1405/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147274644 CMS
Karyopharm Therapeutics Inc. $24.2605/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145531060 CMS
Sumitomo Pharma America, Inc. $18.6205/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148900233 CMS
ABBVIE INC. $24.5505/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105173976 CMS
ABBVIE INC. $0.7605/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105173978 CMS
Novartis Pharmaceuticals Corporation $29.2005/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087232057 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.9705/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144964620 CMS
Daiichi Sankyo Inc. $27.2304/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089465840 CMS
Janssen Biotech, Inc. $17.8204/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078295605 CMS
Exelixis Inc. $37.5104/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138559072 CMS
ARRAY BIOPHARMA INC $16.3104/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131459678 CMS
PUMA BIOTECHNOLOGY, INC. $27.6004/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1113842767 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.4904/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118158727 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $30.7004/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152157009 CMS
Celgene Corporation $16.1404/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101142894 CMS
EMD Serono, Inc. $29.0004/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120228544 CMS
Exelixis Inc. $31.8104/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138559074 CMS
Janssen Biotech, Inc. $8.8704/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078295953 CMS
Lilly USA, LLC $16.6804/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135049642 CMS
RECORDATI_RARE_DISEASES_INC. $24.0404/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139165416 CMS
Merck Sharp & Dohme LLC $25.0204/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141741448 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.3704/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086139887 CMS
E.R. Squibb & Sons, L.L.C. $10.5904/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101465082 CMS
Novartis Pharmaceuticals Corporation $23.9104/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087232059 CMS
Janssen Biotech, Inc. $22.1804/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078295567 CMS
Lilly USA, LLC $28.2904/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135027888 CMS
PFIZER INC. $28.4204/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131559001 CMS
Merck Sharp & Dohme LLC $33.6304/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141741296 CMS
Astellas Pharma US Inc $14.2804/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139349622 CMS
Astellas Pharma US Inc $26.7304/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139359031 CMS
Blueprint Medicines Corporation $24.8304/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147443080 CMS
Alexion Pharmaceuticals, Inc. $34.2604/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093979671 CMS
AstraZeneca Pharmaceuticals LP $23.8104/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104302606 CMS
AstraZeneca Pharmaceuticals LP $10.1804/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105631459 CMS
Janssen Biotech, Inc. $10.1904/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078295927 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,304.61 322
PY2020 $5,339.64 303
PY2021 $6,218.12 325
PY2022 $6,396.31 346
PY2023 $6,939.00 351
PY2024 $7,888.97 348
PY2025 $8,105.08 333

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $96,505.50 3
PY2024 Principal investigator $13,150.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $14,535.50 11/20/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1235996173
Principal investigator 1 Celgene Corporation $55,585.00 06/25/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306877
Principal investigator 1 Celgene Corporation $26,385.00 04/23/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306937